Literature DB >> 11331033

In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users.

H V Curran1, L Monaghan.   

Abstract

AIMS: Ketamine, a non-competitive NMDA receptor antagonist, produces acute impairments of working, episodic and semantic memory along with psychotogenic and dissociative effects when a single dose is given to healthy volunteers. In recreational users, Curran & Morgan (2000) showed that ketamine produced the same acute effects but that 3 days after ingestion, ketamine users showed persisting memory impairment and elevated psychotogenic symptoms compared with controls. To explore whether such persisting effects reflect chronic effects of ketamine use, the present study compared frequent with infrequent users of ketamine on the night of drug use and again 3 days later. DESIGN AND PARTICIPANTS: Eighteen frequent and 19 infrequent ketamine users were assessed on each test day on a range of cognitive tasks tapping memory and attentional function and on subjective scales (schizotypal symptomatology, dissociation, mood).
FINDINGS: Groups were broadly matched for polydrug use apart from ketamine which frequent users took significantly more often and in larger quantities than infrequent users. Acute effects on day 0 replicated previous findings. On day 3 frequent users showed significant impairments on tasks tapping episodic and semantic memory but there was no evidence of persisting dissociative or schizotypal symptoms.
CONCLUSION: These findings indicate that frequent use of ketamine produces long-lasting impairments in episodic memory and aspects of retrieval from semantic memory. Such effects accord with animal evidence of the effects of NMDA receptor blockade on memory. Those using, or contemplating using ketamine should be informed of these persisting, detrimental effects of the drug upon human memory.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331033     DOI: 10.1046/j.1360-0443.2001.96574910.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  37 in total

Review 1.  Glutamatergic model psychoses: prediction error, learning, and inference.

Authors:  Philip R Corlett; Garry D Honey; John H Krystal; Paul C Fletcher
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

Review 2.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 3.  Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.

Authors:  Mark J Niciu; Ioline D Henter; David A Luckenbaugh; Carlos A Zarate; Dennis S Charney
Journal:  Annu Rev Pharmacol Toxicol       Date:  2014       Impact factor: 13.820

4.  Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers.

Authors:  Xiaoyin Ke; Yi Ding; Ke Xu; Hongbo He; Minling Zhang; Daping Wang; Xuefeng Deng; Xifan Zhang; Chao Zhou; Yuping Liu; Yuping Ning; Ni Fan
Journal:  Drug Alcohol Depend       Date:  2014-07-11       Impact factor: 4.492

Review 5.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

6.  Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia.

Authors:  Jinsong Tang; Hannah L Morgan; Yanhui Liao; Philip R Corlett; Dong Wang; Hong Li; Yanqing Tang; Jindong Chen; Tieqiao Liu; Wei Hao; Paul C Fletcher; Xiaogang Chen
Journal:  Psychopharmacology (Berl)       Date:  2014-11-19       Impact factor: 4.530

7.  Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.

Authors:  Ke Xu; John H Krystal; Yuping Ning; Da Chun Chen; Hongbo He; Daping Wang; Xiaoyin Ke; Xifan Zhang; Yi Ding; Yuping Liu; Ralitza Gueorguieva; Zuoheng Wang; Diana Limoncelli; Robert H Pietrzak; Ismene L Petrakis; Xiangyang Zhang; Ni Fan
Journal:  J Psychiatr Res       Date:  2014-12-24       Impact factor: 4.791

8.  Patterns of polydrug use among ketamine injectors in New York City.

Authors:  Stephen E Lankenau; Michael C Clatts
Journal:  Subst Use Misuse       Date:  2005       Impact factor: 2.164

9.  Ketamine impairs multiple cognitive domains in rhesus monkeys.

Authors:  Michael A Taffe; Sophia A Davis; Tannia Gutierrez; Lisa H Gold
Journal:  Drug Alcohol Depend       Date:  2002-10-01       Impact factor: 4.492

10.  Ketamine impairs response inhibition and is positively reinforcing in healthy volunteers: a dose-response study.

Authors:  Celia J A Morgan; Ali Mofeez; Brigita Brandner; Lesley Bromley; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.